| Office of the Inspector General

Astellas Pharma US Inc. Pays $7.3 Million to Resolve False Claims Act Allegations Relating to Marketing of Drug Mycamine

Astellas Pharma US Inc. Pays $7.3 Million to Resolve False Claims Act Allegations Relating to Marketing of Drug Mycamine

Report of Inspection: The DC Office on Aging - Hattie Holmes Senior Wellness Center

DC Teachers' and Police Officers and Firefighters' Retirement Funds - Management Letter Report For the Year Ended September 30, 2013

DC College Savings Program Trust Participant and Administrative Funds Financial Statements With Independent Auditors’ Report - Fiscal Year Ended September 30, 2013

DC Teachers' and Police Officers and Firefighters' Retirement Fund - Financial Statements and Independent Auditor's Report For the Years Ended September 30, 2013, and 2012

DC Tobacco Settlement Financing Corporation – Financial Statements and Independent Auditor’s Report – Years Ended September 30, 2013, and 2012

DC Housing Finance Agency – Financial Statements and Independent Auditors’ Report – For the Years Ended September 30, 2013, and 2012

Significant Activity Report Regarding the Plea and Sentencing of a Member of the Public Who Pled Guilty to One Count of Fraud in the Second Degree for Defrauding the Department of Employment Services

Audit of Construction Management at the District Department of Transportation

Health Benefit Exchange Authority - Financial Statements With Independent Auditors’ Report - Fiscal Year Ended September 30, 2013

« First
‹ Previous
…
77
78
79
80
81
82
83
84
85
…
Next ›
Last »

Office Hours

Monday to Friday, 8:30 am to 5 pm,
except District holidays

Connect With Us

100 M Street, S.E.
Suite 1000
Washington, DC 20003

Phone: 202-727-2540
Fax: 202-727-9903
TTY: 711

Email Us

Ask The Inspector General